Stemedica takes over Smith & Nephew cell production plant
Stemedica Cell Technologies has expanded its manufacturing operation into Europe by taking over a facility from Smith & Nephew.
Stemedica Cell Technologies has expanded its manufacturing operation into Europe by taking over a facility from Smith & Nephew.
Dyadic has agreed to sell its enzyme-producing fungal expression system and the rest of its industrial technology business to DuPont for $75 million (€70 million).
GE Healthcare has teamed up with Emerson Process Management to offer biomanufacturers increased automation from its single-use technologies.
Merck & Co. will file the first antibacterial monoclonal antibody by the end of 2015, the company says.